Pembrolizumab induced steroid resistant immune mediated colitis and concurrent Clostridioides difficile infection

Authors

  • Carmen Monica Preda Carol Davila University of Medicine and Pharmacy, Gastroenterology and Hepatology Department, Fundeni Clinic Institute, Bucharest, Romania
  • Raluca Ioana Marin Gastroenterology and Hepatology Department, Fundeni Clinic Institute, Bucharest, Romania
  • Gabriel Becheanu Carol Davila University of Medicine and Pharmacy, Morphopathology Department, Fundeni Clinic Institute, Bucharest, Romania
  • Florina Neacsu Carol Davila University of Medicine and Pharmacy, Morphopathology Department, Fundeni Clinic Institute, Bucharest, Romania
  • Teodora Manuc Carol Davila University of Medicine and Pharmacy, Gastroenterology and Hepatology Department, Fundeni Clinic Institute, Bucharest, Romania
  • Mircea Manuc Carol Davila University of Medicine and Pharmacy, Gastroenterology and Hepatology Department, Fundeni Clinic Institute, Bucharest, Romania

DOI:

https://doi.org/10.15403/jgld-3923

Keywords:

immune checkpoint inhibitor, induced colitis, immune mediated colitis, Pembrolizumab, steroid-refractory

Downloads

Published

2021-09-22

How to Cite

1.
Preda CM, Marin RI, Becheanu G, Neacsu F, Manuc T, Manuc M. Pembrolizumab induced steroid resistant immune mediated colitis and concurrent Clostridioides difficile infection. JGLD [Internet]. 2021 Sep. 22 [cited 2026 May 2];30(3):411-3. Available from: https://www.jgld.ro/jgld/index.php/jgld/article/view/3923

Issue

Vol. 30 No. 3: September 2021

Section

Letters